Status:
COMPLETED
Adapting a Web-Based Professional Development for Mexican School Mental Health Providers Delivering Evidence-Based Intervention for ADHD and ODD
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
ADHD
Oppositional Defiant Disorder
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
Neurodevelopmental disorders of inattention and disruptive behavior, such as Attention-Deficit/ Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD), are among the most common youth m...
Eligibility Criteria
Inclusion
- Students meeting the following criteria are eligible:
- at least six inattention symptoms and/or six hyperactive/impulsive symptoms endorsed by parent or teacher as occurring often or very often,
- at least one area of impairment rated as concerning by both parent and teacher, and
- a parent and teacher agreeing to participate.
- Students taking medication are eligible as long as regimens were stable.
- Parents and teachers and school clinicians of participating are eligible to participate.
Exclusion
- All Participants: Anyone who does not speak and read Spanish will be excluded, given that all informed consent, measurement, and activity procedures will be conducted in Spanish.
- Child Participants
- Children taking medication will be eligible for screening after the child has been on a stable medication regimen for at least one month (to minimize chance that treatment effects are due to medication and not the proposed program).
- Presence of conditions that are incompatible with this study's treatment.
- severe visual or hearing impairment,
- severe language delay,
- psychosis,
- Child does not read or speak Spanish (inability to complete assessment measures or participate in group treatments).
- Child is in an all-day special education classroom. Children in these classrooms are frequently receiving intensive behavior modification programs and assistance such that the teacher consultation component would be expected to require modification for use in these settings.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT05425966
Start Date
September 1 2021
End Date
June 30 2022
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF
San Francisco, California, United States, 94104